Publications

Data set for describing resistance and identifying risk factors for resistance to Mycobacterium tuberculosis, among highly TB exposed gold miners in South Africa.

FIELDING, K;

2021

, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2021). 10.17037/DATA.00002424.

Food for thought: addressing undernutrition to end tuberculosis.

Sinha, P; Lönnroth, K; Bhargava, A; Heysell, SK; Sarkar, S; Salgame, P; Rudgard, W; BOCCIA, D; Van Aartsen, D; Hochberg, NS;

2021

The Lancet. Infectious diseases, (2021).21 10 10.1016/s1473-3099(20)30792-1.

Dynamics of sputum conversion during effective tuberculosis treatment: A systematic review and meta-analysis.

CALDERWOOD, CJ; Wilson, JP; FIELDING, KL; Harris, RC; Karat, AS; MANSUKHANI, R; FALCONER, J; Bergstrom, M; Johnson, SM; MCCREESH, N; MONK, EJ M; Odayar, J; Scott, PJ; Stokes, SA; Theodorou, H; MOORE, DA J;

2021

PLoS medicine, (2021).18 4 10.1371/journal.pmed.1003566.

Population pharmacokinetics and pharmacodynamics of investigational regimens' drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial.

Nyang'wa, B-T; Kloprogge, F; MOORE, DA J; BUSTINDUY, A; Motta, I; Berry, C; Davies, GR;

2021

BMJ open, (2021).11 9 10.1136/bmjopen-2020-047185.

Whole genome sequencing reveals large deletions and other loss of function mutations in Mycobacterium tuberculosis drug resistance genes.

Gomes, LC; CAMPINO, S; Marinho, CR F; CLARK, TG; PHELAN, JE;

2021

Microbial genomics, (2021).7 12 10.1099/mgen.0.000724.

Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan.

Khan, AS; PHELAN, JE; Khan, MT; Ali, S; Qasim, M; Napier, G; CAMPINO, S; Ahmad, S; Cabral-Marques, O; Zhang, S; Rahman, H; Wei, D-Q; CLARK, TG; Khan, TA;

2021

Scientific reports, (2021).11 1 10.1038/s41598-021-93501-4.

Comparing the performance of QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube among highly TB exposed gold miners in South Africa.

Ntshiqa, T; Chihota, V; MANSUKHANI, R; Nhlangulela, L; Velen, K; Charalambous, S; Maenetje, P; Hawn, T; Wallis, R; GRANT, A; Fielding, K; Churchyard, G;

2021

Gates Open Research, (2021).5, 10.12688/gatesopenres.13191.1.

Adjunctive host-directed therapies for pulmonary tuberculosis: data from a prospective, open-label, phase 2, randomised controlled trial.

FIELDING, K;

2021

, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2021). 10.17037/DATA.00002277.

BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial.

GLYNN, JR; FIELDING, K; Mzembe, T; Sichali, L; Banda, L; MCLEAN, E; Kanjala, C; CRAMPIN, AC; Ponnighaus, JM; Warndorff, DK; FINE, PE M; Karonga Prevention Trial Group,;

2021

The Lancet. Global health, (2021).9 10 10.1016/S2214-109X(21)00309-0.

Design and execution of a public randomization ceremony to enhance stakeholder engagement within a cluster randomized trial to improve tuberculosis diagnosis in Uganda.

Reza, TF; Nalugwa, T; Nantale, M; Adams, K; FIELDING, K; Nakaweesa, A; Oyuku, D; Nabwire, S; Musinguzi, J; Ojok, C; Babirye, D; Ackerman, SL; Handley, MA; Kityamuwesi, A; Dowdy, DW; MOORE, DA J; Davis, JL; Turyahabwe, S; Katamba, A; Cattamanchi, A;

2021

Contemporary clinical trials communications, (2021).22, 10.1016/j.conctc.2021.100707.